This inventor holds 8 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Venatorx Pharmaceuticals, Inc., Aquinox Pharmaceuticals (Canada) Inc., Hovione Scientia Limited. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2018-2025
Title: Innovations of Ana Fernandez Casares
Introduction
Ana Fernandez Casares is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly in the development of beta-lactamase inhibitors. With a total of eight patents to her name, her work has been instrumental in advancing treatments for bacterial infections.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof." This patent describes crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. These crystalline forms are formulated for treating subjects in need of intervention for bacterial infections. The innovative nature of her work lies in the potential effectiveness of these compositions in combating resistant bacterial strains.
Career Highlights
Ana has worked with notable companies in the pharmaceutical industry, including Venatorx Pharmaceuticals, Inc. and Aquinox Pharmaceuticals (Canada) Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to significant advancements in drug development.
Collaborations
Some of her notable coworkers include Christopher J. Burns and Daniel C. Pevear. Their collaborative efforts have further enhanced the impact of her inventions in the pharmaceutical landscape.
Conclusion
Ana Fernandez Casares is a distinguished inventor whose work in beta-lactamase inhibitors has the potential to revolutionize treatments for bacterial infections. Her contributions to the field are marked by her innovative patents and collaborations with industry leaders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile